Skip to content

Hydration and Exercise Performance in Cycling

How Does Altering the Composition of Ingested Fluids Affect Hydration Status Whilst Cycling?

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03304197
Enrollment
15
Registered
2017-10-06
Start date
2017-09-11
Completion date
2018-06-01
Last updated
2018-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

This study will evaluate the effects manipulating ingested fluids can have on hydration status and cycling performance. There will be 4 different conditions.

Detailed description

Being dehydrated can decrease endurance exercise performance. The investigators wish to test which of three drinks is most effective at re-hydrating cyclists and if this affects performance. Subjects will undertake 4 tests: once dehydrated, once hydrated with water, once hydrated with a sports-specific drink, and once with an altered sports drink. Blood samples will be taken and expired gasses will be sampled at various time points throughout the tests for later analysis. A small amount of labelled water will be consumed with each drink, a technique which will allow us to quantify the absorption of each of the drinks.

Interventions

DIETARY_SUPPLEMENTHypotonic

N/A: see arm description

DIETARY_SUPPLEMENTIsotonic

N/A: see arm description

DIETARY_SUPPLEMENTPlacebo

N/A: see arm description

OTHERDehydrated

N/A: see arm description

Sponsors

University of Exeter
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Masking description

Doubly-blinded & randomised using an online randomisation website.

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Highly trained cyclists (vo2max \>55 ml/kg/min, PPO (peak power output) \> 4 w/kg) * Training at least 4 times a week * Females must be taking an oral contraceptive, or using the contraceptive implant

Exclusion criteria

* Recent history of musculoskeletal injury * Diagnosed cardiovascular disease * Regular use of nutritional supplements that may interfere with the protocol

Design outcomes

Primary

MeasureTime frameDescription
Absorption of fluid through the gutTo begin 10 minutes after the completion of the 90 minute steady-state cycleAbsorption of drinks through the gut will be measured using 2 boluses of deuterated water. This will be consumed alongside 2 of the drinks, and blood samples will be used to quantify enrichment. Total body water calculations are required to provide corrections in equations related to D2O. H218O will be consumed in order to quantify total body water: this will be provided in a single bolus before each trial.

Secondary

MeasureTime frameDescription
Work done (kJ) during 15 minute cycling time-trialThroughout the 90 minute steady-state cycle & the 15 minute time trial.Subjects will perform a cycle ergometer protocol that has been shown to be reproducible in athletes. Subjects will complete the time trial on a Lode Excalibur cycling ergometer. Software linked to this software will record work done and power output.

Other

MeasureTime frameDescription
Heart rateThroughout the 90 minute steady-state cycle and time-trialHeart rate will be measured throughout with the use of a heart rate monitor.
Substrate utilisationThroughout the 90 minute steady-state cycleSubstrate utilisation will be calculated from data collected through a metabolic cart and its software. It will be measured during the 90-minute steady-state cycle for 4 periods of 3 minutes. Carbohydrate and lipid oxidation rates will be calculated using equations by Jeukendrup & Wallis (2005).
Core body temperatureThroughout the 90 minute steady-state cycle and time-trialCore temperature will be measured throughout with the use of an ingestible core-body temperature pill (HQ Inc, FL, USA).
RPE (rating of perceived exertion)Throughout the 90 minute steady-state cycle and time-trialRPE will be measured using the Borg Scale.
Plasma metabolitesThroughout the 90 minute steady-state cycle and time-trialA cannula will be used to draw blood from subjects at several time points. Whole blood samples will be analysed immediately for plasma glucose, plasma lactate, haemoglobin content, haematocrit and plasma volume. Remaining whole blood will be centrifuged immediately and its plasma split into aliquots and stored in a -20°C freezer. At the end of the trial, plasma samples will be moved to a -80°C freezer for later analysis for sodium, glycerol, and NEFA.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026